Table 2. Taurine concentration in tissues and plasma following taurine supplementation for 3 weeks. Values are mean ± SD.
| Tissue |
|
3wCon/Sed |
3wTau/Sed |
3wCon/Exe |
3wTau/Exe |
| GC-W |
(nmol·mg-1) |
13.8 (.3) |
21.0 (.3) ‡ |
14.1 (.3) |
20.1 (.3) ‡* |
| GC-R |
(nmol·mg-1) |
21.4 (.7) |
29.0 (.7) ‡ |
21.7 (.7) |
27.8 (.7) ‡ |
| Plantaris |
(nmol·mg-1) |
18.3 (.6) |
24.0 (.6) ‡ |
17.8 (0.6) |
23.3 (.6) ‡ |
| Liver |
(nmol·mg-1) |
2.1 (1.8) |
17.9 (1.8) ‡ |
5.0 (2.0) |
13.2 (1.8) ‡ |
| Plasma |
(nmol·mg-1) |
326 (288) |
876 (561) ‡ |
481 (396) |
1201 (430) ‡ |
‡, p < 0.01 for the significant difference to the respective non-supplemented control group by two-way ANOVA.*, p < 0.05 for the significant difference to the 3wTau/Sed group by two-way ANOVA followed by Bonferroni’s post hoc analysis.Abbreviations: 3wCon/Sed; three-week non-supplemented and sedentary group, 3wTau/Sed; three-week taurine-supplemented and sedentary group, 3wCon/Exe; three-week non-supplemented and exercised group, 3wCon/Exe; three-week taurine-supplemented and exercised group, and see the footnote of for other abbreviations.
